- Sourcews Report
- File
- HTML
- Size
- 30 Ko
- URL response
- 100%
- Source quality
- 100%
- Sourcews Explorer
European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion For Once-Daily PREZISTAŽ (darunavir) as Part of Combination Therapy for Treatment-Naīve Adults With HIV-1
28.11.08 - 16:02 ... source : Johnson & Johnson
... » Next (HTML)
Similar news
100% | 03.10.08 - 14:22 ... source : Lilly
... -- The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Zypadhera (olanzapine powder and solvent for prolonged release suspension for injection, also known as olanzapine long-acting injection) for maintenance treatment of adult ...
92% | 17.11.08 - 22:43 ... source : European Medicines Agency - EMA
... 4HB, UK Tel. (44-20 ) 74 18 84 00 Fax (44-20 ) 74 18 86 68 E-mail: mail@emea.europa.eu http://www.emea.europa.eu London 10 November 2008 EMEA/557896/2008 PUBLIC STATEMENT ON Exubera (Insulin human ) WITHDRAWAL OF THE MARKETING AUTHORISATION IN THE EUROPEAN UNION ...
91% | 15.10.08 - 13:40 ... source : Roland Berger Strategy Consultants
... widely recognized problems: high volatility and the cyclical nature of the business. The question that companies must answer is how to manage these challenges effectively. The current situation on the market is such that many companies need to take urgent ...
91% | 19.11.08 - 18:59 ... source : Santhera Pharmaceuticals
... company focused on neuromuscular diseases, announced today that the European Medicines Agency (EMEA) has informally advised that it would maintain its negative opinion on the Company's Marketing Authorization Application (MAA) for SNT-MC17/idebenone in Friedreich's Ataxia. According to the information received, ...
90% | 24.10.08 - 14:56 ... source : Lilly
... -- The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a negative opinion on a Cymbalta(R) (duloxetine hydrochloride) application for the treatment of fibromyalgia. "Eli Lilly and Company and Boehringer Ingelheim are ...
